绿豆胰蛋白酶抑制剂片段及其类似物的合成

绿豆胰蛋白酶抑制剂的Lys活性碎片由两条分别含有26及9个氯基酸残基的多肽链通过两对分子间二硫键连接而成。用DTT还原能拆分两链,其中长链含6个半胱氨酸,在空气中氧化后能恢复25％原Lys碎片活力。本文报道了此长链的化学合成和二硫键重组。合成产物的氯基酸组成与文献报道的一致。但活性明显低于天然产物。为此对绿豆抑制剂的部分序列重新进行测定,结果表明原P_2′位的Lys应为Ile按新测定序列,从长链26肽的N端和C端各去掉两个残基合成一个22肽,此22肽的活性与天然的26肽相当。此外还合成了此22肽的类似物,其活性中心的Lys残基由Ala取代,产物对胰蛋白酶和弹性蛋白酶都无抑制活力。     

ENZYMATIC SYNTHESIS OF DESHEXAPEPTIDE INSULIN AND ITS ANALOGUES

Enzymatic synthesis of deshexapeptide (B25-B30) insulin (DHI) was reported briefly in previous papers, In this article, the optimal pH of enzymatic synthesis from desoctapeptide (B23-B30) insulin (DOI) protected by methylsulphonylethoxycarbonyl (Msc) groups, in vivo biological activity of crystalline DHI, its binding capacity with insulin receptor on human placental membrane and its conformation in solution is reported. The marked difference between the in vivo activity of DHI (40%) and its receptor-binding capacity (2％) is discussed.Homogeneous B23 Ala DHI has been prepared by the same method but the enzymatic synthesis of B23 D-Ala DHI has proved unsuccessful because of the high optical specificity of the enzyme.     

THE STRUCTURE BASIS OF THE POOR FIBRIN SPECIFICITY OF UROKINASE(Ⅱ)——THE INHIBITION OF UROKINASE A CHAIN 149--157 ON THE FIBRIN STIMULATED ACTIVATION OF PLASMINOGEN BY TISSUE TYPE PLASMINOGEN ACTIVATOR

In view of the similarity of the charge distribution between fibrin A_α148--161 and Achain 149--157 of urokinase,the latter might compete with fibrin A_α148--161 when singlechain pro-urokinase is converted to double chain urokinase.To test this, the stretch of uro-kinase A chain 135--157 was separated from the low molecular weight urokinase, a competi-tive binding between this stretch and fibrin to tPA kringle-2 was shown by radio-bindingassay. The inhibition of the stretch on the fibrin stimulated activation of plasminogen wasdemonstrated in the caseinolytic system. The synthesized novapeptide urokinase A chain 149--157 (R-peptide) showed a significant inhibition on the activation of plasminogen in the pres-ence of fibrin. By contrasting finely with R-peptide, a synthesized novapeptide in which Arg154and Arg156 were replaced by Asp (D-peptide) did not show any inhibition effect on the fi-brin stimulated activation of plasminogen by tPA. These results suggest that the positivelycharged residues in the     

去B链C端六肽胰岛素及其类似物的酶促合成

本文报道了用胰蛋白酶合成肽键的方法从[Msc]_2-DOI制备结晶的DHI和均一的B23-Ala-DHI。酶促合成的最适pH为7.0—7.5。结晶DHI的整体活力为胰岛素活力的40％,而与人胎盘细胞膜胰岛素受体的结合能力只有胰岛素的2.1％。对于这一差异进行了讨论。B23-Ala-DHI的整体活力只有胰岛素活力的2％。本文还报道了结晶DOI以及DHI等胰岛素类似物的CD光谱。     

尿激酶对纤维蛋白低亲和性的结构基础——Ⅱ.尿激酶A链149—157片段对纤维蛋白促进tPA激活纤溶酶原的抑制作用

本文从低分子量尿激酶(LUK)中分离并纯化了UK 135—157片段,用放射结合分析证明UK 135—157片段和纤维蛋白对tPA的结合呈竞争关系。用酪蛋白降解系统证明此片段可抑制纤维蛋白促进tPA对纤溶酶原的激活。化学合成了UK149—157九肽(R-肽)以及由Asp取代Arg 154和Arg 156的相应九肽(D-肽),发现R-肽对纤维蛋白促进tPA激活纤溶酶原有显著的抑制作用,而D-肽却全无作用。本文结果证明:UK 149—157片段中的正电荷残基在抑制环饼结构域的纤维蛋白结合活性中起重要作用。     

孤啡肽OFQ的溶液构象研究

应用近代NMR波谱技术对孤啡肽OFQ及其片段OFQ_(8-17)的溶液结构进行了比较 研究，测定了孤啡肽OFQ和片段OFQ_(8-17)在H_2O和TEF/H_2O两种溶剂条件下的2D －DQF－COSY，2D－TOCSY，2D－NOSESY(ROESY)谱，完成了它们氨基酸残基的处旋 系统识别和序列特异性归属，获得分子中质子化学位移的完全归属，根据NOE特征 和主链偶合常数等结构参数确定了它们的特征二级结构，以NOE提供的距离约束， 进行何，分子力学和分子动力学模拟，得到了孤啡肽OFQ在不同溶剂条件下的溶液 结构。在H_2O溶济中，孤啡肽OFQ在G3－F4－T5－G6处形成一复合型转角结构。在 TFE/H_2O溶剂中，OFQ整个分子形成两新性α－螺旋结构。而孤啡肽片OFO_(8-17) 在这两种环境中均为伸展的无规结构。孤啡肽OFQ在类似膜环境(TFE/H_2O)下的α 螺旋结构可能为其活性构象。